The animal pharmacology of drugs used in the treatment of migraine.
D000082:Acetaminophen / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D003533:Cyproheptadine / Q000494:pharmacology; D004087:Dihydroergotamine / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D006801:Humans; D008784:Methysergide / Q000494:pharmacology; D008881:Migraine Disorders / Q000188:drug therapy*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D010918:Pizotyline / Q000494:pharmacology; D012702:Serotonin Antagonists; D013564:Sympathetic Nervous System / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects; D014363:Tryptamines / Q000037:antagonists & inhibitors; D014630:Vagus Nerve / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000700:Analgesics; D008996:Monoamine Oxidase Inhibitors; D012702:Serotonin Antagonists; D014363:Tryptamines; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D010918:Pizotyline; D003533:Cyproheptadine; D000082:Acetaminophen; D002110:Caffeine; D004087:Dihydroergotamine; D003000:Clonidine; D004878:Ergotamine; D001241:Aspirin; D008784:Methysergide